Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 34INDUSTRY 4OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Conditions

Malignant Female Reproductive System Neoplasm 1Hemorrhage 1Anastomotic Leak 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Enoxaparin × Clear all
NCT06049758 2023-09-22

D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy

General Committee of Teaching Hospitals and Institutes, Egypt

Phase NA Not yet recruiting
80 enrolled

Hemorrhage, Anastomotic Leak

NCT01356329 2016-05-13

Lovenox

National Guard Health Affairs

Phase 3 Suspended
150 enrolled

Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡